Literature DB >> 31102768

Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils.

Isabella Russo1, Alice Kaganovich2, Jinhui Ding3, Natalie Landeck4, Adamantios Mamais5, Tatiana Varanita6, Alice Biosa7, Isabella Tessari8, Luigi Bubacco9, Elisa Greggio10, Mark R Cookson11.   

Abstract

Several previous studies have linked the Parkinson's disease (PD) gene LRRK2 to the biology of microglia cells. However, the precise ways in which LRRK2 affects microglial function have not been fully resolved. Here, we used the RNA-Sequencing to obtain transcriptomic profiles of LRRK2 wild-type (WT) and knock-out (KO) microglia cells treated with α-synuclein pre-formed fibrils (PFFs) or lipopolysaccharide (LPS) as a general inflammatory insult. We observed that, although α-synuclein PFFs and LPS mediate overlapping gene expression profiles in microglia, there are also distinct responses to each stimulus. α-Synuclein PFFs trigger alterations of oxidative stress-related pathways with the mitochondrial dismutase Sod2 as a strongly differentially regulated gene. We validated SOD2 at mRNA and protein levels. Furthermore, we found that LRRK2 KO microglia cells reported attenuated induction of mitochondrial SOD2 in response to α-synuclein PFFs, indicating a potential contribution of LRRK2 to oxidative stress-related pathways. We validate several genes in vivo using single-cell RNA-Seq from acutely isolated microglia after striatal injection of LPS into the mouse brain. Overall, these results suggest that microglial LRRK2 may contribute to the pathogenesis of PD via altered oxidative stress signaling.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  LRRK2; Microglia; Neuroinflammation; Oxidative stress; Parkinson's disease; α-Synuclein

Mesh:

Substances:

Year:  2019        PMID: 31102768      PMCID: PMC6749993          DOI: 10.1016/j.nbd.2019.05.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  57 in total

1.  Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders.

Authors:  Jenna M Puccini; Daniel F Marker; Tim Fitzgerald; Justin Barbieri; Christopher S Kim; Patrick Miller-Rhodes; Shao-Ming Lu; Stephen Dewhurst; Harris A Gelbard
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

2.  Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders.

Authors:  Stefano G Daniele; Dawn Béraud; Connor Davenport; Kui Cheng; Hang Yin; Kathleen A Maguire-Zeiss
Journal:  Sci Signal       Date:  2015-05-12       Impact factor: 8.192

3.  Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.

Authors:  Melanie B Watson; Franziska Richter; Soo Kyung Lee; Lauryn Gabby; Jennifer Wu; Eliezer Masliah; Rita B Effros; Marie-Françoise Chesselet
Journal:  Exp Neurol       Date:  2012-06-27       Impact factor: 5.330

4.  Exosomes-associated neurodegeneration and progression of Parkinson's disease.

Authors:  Isabella Russo; Luigi Bubacco; Elisa Greggio
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

5.  Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes.

Authors:  Corinna Bliederhaeuser; Veselin Grozdanov; Anna Speidel; Lisa Zondler; Wolfgang P Ruf; Hanna Bayer; Martin Kiechle; Marisa S Feiler; Axel Freischmidt; David Brenner; Anke Witting; Bastian Hengerer; Marcus Fändrich; Albert C Ludolph; Jochen H Weishaupt; Frank Gillardon; Karin M Danzer
Journal:  Acta Neuropathol       Date:  2015-11-17       Impact factor: 17.088

6.  Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.

Authors:  Changyoun Kim; Dong-Hwan Ho; Ji-Eun Suk; Sungyong You; Sarah Michael; Junghee Kang; Sung Joong Lee; Eliezer Masliah; Daehee Hwang; He-Jin Lee; Seung-Jae Lee
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.

Authors:  P L McGeer; S Itagaki; B E Boyes; E G McGeer
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

8.  LRRK2 levels in immune cells are increased in Parkinson's disease.

Authors:  D A Cook; G T Kannarkat; A F Cintron; Laura M Butkovich; Kyle B Fraser; J Chang; N Grigoryan; S A Factor; Andrew B West; J M Boss; M G Tansey
Journal:  NPJ Parkinsons Dis       Date:  2017-03-28

Review 9.  LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?

Authors:  Isabella Russo; Luigi Bubacco; Elisa Greggio
Journal:  J Neuroinflammation       Date:  2014-03-21       Impact factor: 8.322

10.  Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells.

Authors:  Isabella Russo; Giulia Berti; Nicoletta Plotegher; Greta Bernardo; Roberta Filograna; Luigi Bubacco; Elisa Greggio
Journal:  J Neuroinflammation       Date:  2015-12-09       Impact factor: 8.322

View more
  18 in total

1.  Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.

Authors:  Adamantios Mamais; Jillian H Kluss; Luis Bonet-Ponce; Natalie Landeck; Rebekah G Langston; Nathan Smith; Alexandra Beilina; Alice Kaganovich; Manik C Ghosh; Laura Pellegrini; Ravindran Kumaran; Ioannis Papazoglou; George R Heaton; Rina Bandopadhyay; Nunziata Maio; Changyoun Kim; Matthew J LaVoie; David C Gershlick; Mark R Cookson
Journal:  PLoS Biol       Date:  2021-12-16       Impact factor: 8.029

Review 2.  Role of Nrf2 in Parkinson's Disease: Toward New Perspectives.

Authors:  Xin-Xing Yang; Rong Yang; Feng Zhang
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

Review 3.  Microglia and astrocyte dysfunction in parkinson's disease.

Authors:  Tae-In Kam; Jared T Hinkle; Ted M Dawson; Valina L Dawson
Journal:  Neurobiol Dis       Date:  2020-07-28       Impact factor: 5.996

Review 4.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

Review 5.  Gut Inflammation in Association With Pathogenesis of Parkinson's Disease.

Authors:  Qian-Qian Chen; Caroline Haikal; Wen Li; Jia-Yi Li
Journal:  Front Mol Neurosci       Date:  2019-09-13       Impact factor: 5.639

6.  LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis.

Authors:  Chi G Weindel; Samantha L Bell; Krystal J Vail; Kelsi O West; Kristin L Patrick; Robert O Watson
Journal:  Elife       Date:  2020-02-14       Impact factor: 8.140

Review 7.  LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson's.

Authors:  Rebecca L Wallings; Mary K Herrick; Malú Gámez Tansey
Journal:  Front Neurosci       Date:  2020-05-21       Impact factor: 4.677

Review 8.  LRRK2 regulation of immune-pathways and inflammatory disease.

Authors:  Rebecca L Wallings; Malú G Tansey
Journal:  Biochem Soc Trans       Date:  2019-12-20       Impact factor: 5.407

9.  The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo.

Authors:  Noémie Cresto; Camille Gardier; Marie-Claude Gaillard; Francesco Gubinelli; Pauline Roost; Daniela Molina; Charlène Josephine; Noëlle Dufour; Gwenaëlle Auregan; Martine Guillermier; Suéva Bernier; Caroline Jan; Pauline Gipchtein; Philippe Hantraye; Marie-Christine Chartier-Harlin; Gilles Bonvento; Nadja Van Camp; Jean-Marc Taymans; Karine Cambon; Géraldine Liot; Alexis-Pierre Bemelmans; Emmanuel Brouillet
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

Review 10.  Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation.

Authors:  Sandro Percário; Aline da Silva Barbosa; Everton Luiz Pompeu Varela; Antônio Rafael Quadros Gomes; Michelli Erica Souza Ferreira; Thayana de Nazaré Araújo Moreira; Maria Fani Dolabela
Journal:  Oxid Med Cell Longev       Date:  2020-10-12       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.